MedPath

Does Preoperative Pain Medication Management Influence Surgical Outcomes in Spinal Fusion

Not Applicable
Completed
Conditions
Spine Fusion
Opioid Use
Registration Number
NCT04095624
Lead Sponsor
Stanford University
Brief Summary

In light of the current opioid epidemic, there is an urgent need to address chronic opioid use prior to surgery before it is exacerbated by postoperative surgical pain. Our central hypothesis is that patients who taper their opioid use prior to surgery will have reduced postoperative opioid and pain medication usage, less postoperative pain, and improved patient reported outcomes relative to patients that do not taper prior to surgery. Our specific aims include: 1. Determine whether reducing patients' preoperative opioid usage through a structured tapering regimen reduces postoperative opioid and pain medication use. 2. Examine whether reducing patients' preoperative opioid usage through a structured tapering regimen reduces postoperative pain. 3. Determine whether reducing patients' preoperative opioid usage through a structured tapering regimen improves patient reported outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • 18 years of age or older
  • Indicated for lumbar, lumbosacral, or thoracolumbar spinal fusion surgery in the departments of Orthopedic Surgery and Neurosurgery
  • Daily opioid use for at least 4 weeks prior to the preoperative planning appointment
Exclusion Criteria
  • Suboxone (buprenorphine) use
  • Unable to complete patient reported outcome measures (PROMs)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Postoperative Opioid Pain Medication DoseWeekly, month 3, month 6

Weekly average opioid medication use in morphine equivalent dosage (MED)

Change from baseline Patient Reported Outcome Measures (PROMs)Weekly, month 3, month 6

PROMIS computer adaptive testing: global health, physical function, pain interference, pain behavior, depression, anxiety, fatigue, sleep disturbance, and satisfaction with social roles and activities.

Change in Numeric Pain Scale ScoreWeekly, month 3, month 6

Generic measure of average back pain, scale 0-10 with 0 being no pain and 10 being the most pain experienced.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford Hospital and Clinics

🇺🇸

Redwood City, California, United States

Stanford Hospital and Clinics
🇺🇸Redwood City, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.